MicroRNA analysis from acute to convalescence in Crimean Congo hemorrhagic fever.
Crimean Congo hemorrhagic fever
acute
convalescence
miRNA
microarray
Journal
Journal of medical virology
ISSN: 1096-9071
Titre abrégé: J Med Virol
Pays: United States
ID NLM: 7705876
Informations de publication
Date de publication:
08 2021
08 2021
Historique:
received:
15
01
2021
accepted:
25
02
2021
pubmed:
2
3
2021
medline:
15
12
2021
entrez:
1
3
2021
Statut:
ppublish
Résumé
Crimean Congo hemorrhagic fever (CCHF) is one of the most important viral infections and is caused by Crimean Congo hemorrhagic fever orthonairovirus (CCHFV). Severity of CCHF can vary from a mild and nonspecific illness to a severe disease with fatal outcomes. MicroRNAs (miRNAs) have an increasing impact on the different pathways of viral infections. Within the transition process from acute phase to convalescence with 18 CCHF patients, we investigated the impacts on miRNA via microarray for the first time. We also compared miRNA gene expression in 16 severe and 15 mild cases. We identified Kyoto Encyclopedia of Genes and Genomes (KEGG) and Gene Ontology (GO) pathways associated with significant miRNAs utilizing DIANA TOOLS mirPath v.3. In this study, miR-15b-5p and miR-29a-3p were significantly downregulated in statistical terms; miR-4741, miR-937-5p, miR-6068, miR-7110-5p, miR-6126, and miR-7107-5p were upregulated in acute cases in comparison with convalescent patients (p ≤ .05). In total, 28 miRNAs (8 downregulated, 20 upregulated) were differentially expressed in severe CCHF patients as compared with mild cases (p ≤ .05). Whereas miR-6732-3p, miR-4436b-5p, miR-483-3p, and miR-6807-5p had the highest downregulation, miR-532-5p, miR-142-5p, miR-29c-3p, and let-7f-5p had the highest upregulation in severe patients in comparison with mild cases. Consequently, we determined that CCHF-induced miRNAs are associated with antiviral and proinflammatory pathways in acute and severe cases. In comparison with convalescence, these miRNAs in acute period may be therapeutic targets.
Substances chimiques
MicroRNAs
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
4729-4737Informations de copyright
© 2021 Wiley Periodicals LLC.
Références
Al Mussaed E . Transfusion therapy: an overview. J Adv Pharm Edu Res. 2018;8(4):97-104.
Mohamed MS , Zohny YM , El-Senousy WM , Abou El-Elaa AM . Synthesis and biological screening of novel pyrazoles and their precursors as potential antiviral agents. Pharmacophore. 2018;9(1):126-139.
Woolhouse ME , Gowtage-Sequeria S . Host range and emerging and reemerging pathogens. Emerg Infect Dis. 2005;11(12):1842-1847.
Aytekin FY , Barut HS , Rüstemoğlu A , et al. Factors related to fatalities and clinical progression of Crimean-Congo hemorrhagic fever patients and the effects of IL 28-B gene polymorphism. Arch Virol. 2019;164(2):547-557.
Whitehouse CA . Crimean-Congo hemorrhagic fever. Antiviral Res. 2004;64:145-160.
Ergönül Ö . Crimean-Congo haemorrhagic fever. Lancet Infect Dis. 2006;6:203-214.
Bente DA , Forrester NL , Watts DM , McAuley AJ , Whitehouse CA , Bray M . Crimean-Congo hemorrhagic fever: history, epidemiology, pathogenesis, clinical syndrome and genetic diversity. Antiviral Res. 2013;100:159-189.
Vorou R , Pierroutsakos IN , Maltezou HC . Crimean-Congo hemorrhagic fever. Curr Opin Infect Dis. 2007;20:495-500.
Cevik MA , Erbay A , Bodur H , et al. Clinical and laboratory features of Crimean-Congo hemorrhagic fever: predictors of fatality. Int J Infect Dis. 2008;12:374-379.
Burt FJ . Laboratory diagnosis of Crimean-Congo hemorrhagic fever virus. Infections Future Virol. 2011;6:831-841.
Korva M , Resman Rus K , Pavletič M , et al. Characterization of Biomarker Levels in Crimean-Congo hemorrhagic fever and Hantavirus fever with renal syndrome. Viruses. 2019;11(8):686.
Yesilyurt M , Gul S , Ozturk B , et al. The early prediction of fatality in Crimean Congo hemorrhagic fever patients. Saudi Med J. 2011;32:742-743.
Saksida A , Duh D , Wraber B , Dedushaj I , Ahmeti S , Avsic-Zupanc T . Interacting roles of immune mechanisms and viral load in the pathogenesis of Crimean-Congo hemorrhagic fever. Clin Vaccine Immunol. 2010;17:1086-1093.
Burt FJ , Swanepoel R , Shieh WJ , et al. Immunohistochemical and in situ localization of Crimean-Congo hemorrhagic fever (CCHF) virus in human tissues and implications for CCHF pathogenesis. Arch Pathol Lab Med. 1997;121:839-846.
Peyrefitte CN , Perret M , Garcia S , et al. Differential activation profiles of Crimean-Congo hemorrhagic fever virus- and Dugbe virus-infected antigen-presenting cells. J Gen Virol. 2010;91:189-198.
Connolly-Andersen AM , Douagi I , Kraus AA , Mirazimi A . Crimean Congo hemorrhagic fever virus infects human monocyte-derived dendritic cells. Virology. 2009;390:157-162.
Connolly-Andersen AM , Moll G , Andersson C , et al. Crimean-Congo hemorrhagic fever virus activates endothelial cells. J Virol. 2011;85:7766-7774.
Bakır M , Gözel MG , Köksal I , et al. Validation of a severity grading score (SGS) system for predicting the course of disease and mortality in patients with Crimean-Congo hemorrhagic fever (CCHF). Eur J Clin Microbiol Infect Dis. 2015;34(2):325-330.
Vlachos IS , Zagganas K , Paraskevopoulou MD , et al. DIANA-miRPath v3.0: deciphering microRNA function with experimental support. Nucleic Acids Res. 2015;43(W1):W460-W466.
Arslan S , Engin A , Aydemir EI , et al. Identification of potential microRNA markers related to Crimean-Congo hemorrhagic fever disease. J Cell Biochem. 2019;120(9):15506-15517.
Tchesnokov EP , Bailey-Elkin BA , Mark BL , Götte M . Independent inhibition of the polymerase and deubiquitinase activities of the Crimean-Congo hemorrhagic fever virus full-length L-protein. PLoS Negl Trop Dis. 2020;14(6):e0008283.
Demir ZC , Bastug A , Bodur H , Ergunay K , Ozkul A . MicroRNA expression profiles in patients with acute Crimean Congo hemorrhagic fever reveal possible adjustments to cellular pathways. J Med Virol. 2017;89(3):417-422.
Guler N , Eroglu C , Yilmaz H , et al. Apoptosis-related gene expression in an adult cohort with Crimean-Congo hemorrhagic fever. PLoS One. 2016;11(6):e0157247.
Kozak RA , Fraser RS , Biondi MJ , et al. Dual RNA-Seq characterization of host and pathogen gene expression in liver cells infected with Crimean-Congo hemorrhagic fever virus. PLoS Negl Trop Dis. 2020;14(4):e0008105.
Barbu MG , Condrat CE , Thompson DC , et al. MicroRNA involvement in signaling pathways during viral infection. Front Cell Dev Biol. 2020;8:143.
Mukherjee S , Huda S , Sinha Babu SP . Toll-like receptor polymorphism in host immune response to infectious diseases: a review. Scand J Immunol. 2019;90(1):e12771.
Engin A , Arslan S , Kizildag S , et al. Toll-like receptor 8 and 9 polymorphisms in Crimean-Congo hemorrhagic fever. Microb Infect. 2010;12(12-13):1071-1078.
Arslan S , Engin A , Özbilüm N , Bakır M . Toll-like receptor 7 Gln11Leu, c. 4-151A/G, and +1817G/T polymorphisms in Crimean Congo hemorrhagic fever. J Med Virol. 2015;87(7):1090-1095.
Haralambieva IH , Kennedy RB , Simon WL , et al. Differential miRNA expression in B cells is associated with inter-individual differences in humoral immune response to measles vaccination. PLoS One. 2018;13(1):e0191812.
Liu J , Yan J , Zhou C , Ma Q , Jin Q , Yang Z . miR-1285-3p acts as a potential tumor suppressor miRNA via downregulating JUN expression in hepatocellular carcinoma. Tumor Biol. 2015;36(1):219-225.
Gao J , Gao L , Li R , Lai Z , Zhang Z , Fan X . Integrated analysis of microRNA-mRNA expression in A549 cells infected with influenza A viruses (IAVs) from different host species. Virus Res. 2019;263:34-46.
Yousefi H , Poursheikhani A , Bahmanpour Z , et al. SARS-CoV infection crosstalk with human host cell noncoding-RNA machinery: an in-silico approach. Biomed Pharmacother. 2020;130:110548.
Zhang X , Chu H , Wen L , et al. Competing endogenous RNA network profiling reveals novel host dependency factors required for MERS-CoV propagation. Emerg Microbes Infect. 2020;9(1):733-746.
Khongnomnan K , Poomipak W , Praianantathavorn K , et al. Human microRNAs expression profiles in influenza B virus-infected cells based on illumina MiSeq platform. MicroRNA. 2018;7(3):204-214.
Wong JJL , Au AYM , Gao D , et al. RBM3 regulates temperature sensitive miR-142-5p and miR-143 (thermomiRs), which target immune genes and control fever. Nucleic Acids Res. 2016;44(6):2888-2897.
Li C , Hu X , Li L , Li JH . Differential microRNA expression in the peripheral blood from human patients with COVID-19. J Clin Lab Anal. 2020;34(10):e23590.
Li N , Du T , Yan Y , et al. MicroRNA let-7f-5p inhibits porcine reproductive and respiratory syndrome virus by targeting MYH9. Sci Rep. 2016;6:34332.
Li N , Du T , Yan Y , et al. MicroRNA let-7f-5p inhibits porcine reproductive and respiratory syndrome virus by targeting MYH9. Sci Rep. 2016;6:34332.
Zhao Y , Wang Y , Wang Y . Up-regulated miR-500a enhances hepatocarcinoma metastasis by repressing PTEN expression. Biosci Rep. 2017;37:6.
Zhang X , Liu S , Hu T , Liu S , He Y , Sun S . Up-regulated microRNA-143 transcribed by nuclear factor kappa B enhances hepatocarcinoma metastasis by repressing fibronectin expression. Hepatology. 2009;50(2):490-499.
Morishita A , Fujita K , Iwama H , et al. Role of microRNA-210-3p in hepatitis B virus-related hepatocellular carcinoma. Am J Physiol Gastrointest Liver Physiol. 2020;318(3):G401-G409.
Ma Y , Ouyang J , Wei J , Maarouf M , Chen JL . Involvement of host non-coding RNAs in the pathogenesis of the influenza. Virus Int J Mol Sci. 2016;18:18.
Bruscella P , Bottini S , Baudesson C , Pawlotsky JM , Feray C , Trabucchi M . Viruses and miRNAs: more friends than foes. Front Microbiol. 2017;8:824.
Fang J , Hao Q , Liu L , et al. Epigenetic changes mediated by microRNA miR29 activate cyclooxygenase 2 and lambda-1 interferon production during viral infection. J Virol. 2012;86:1010-1020.
Verma P , Pandey RK , Prajapati P , Prajapati VK . Circulating microRNAs: potential and emerging biomarkers for diagnosis of human infectious diseases. Front Microbiol. 2016;7:1274.
Tambyah PA , Sepramaniam S , Mohamed Ali J , et al. microRNAs in circulation are altered in response to influenza A virus infection in humans. PLoS One. 2013;8:e76811.
Qi Y , Zhu Z , Shi Z , et al. Dysregulated microRNA expression in serum of non-vaccinated children with varicella. Viruses. 2014;6:1823-1836.
Egaña-Gorroño L , Escribà T , Boulanger N , et al. Differential microRNA expression profile between stimulated PBMCs from HIV-1 infected elite controllers and viremic progressors. PLoS One. 2014;9:e106360.